PIK3R1: A Potential Drug Target and Biomarker for the Treatment of Various Cancers

Target Name: PIK3R1

NCBI ID: G5295

PIK3R1

PIK3R1: A Potential Drug Target and Biomarker for the Treatment of Various Cancers

Introduction

PI3-kinase regulatory subunit alpha (PI3K-伪) is a protein that plays a crucial role in cell signaling pathways, particularly in the regulation of cell growth, survival, and angiogenesis. It is a key component of the PI3K signaling pathway, which is a well-established target for various diseases, including cancer. The PI3K-伪 protein has also been implicated in cancer progression and the development of resistance to anti-cancer drugs. Therefore, targeting PI3K-伪 has emerged as a promising strategy for the treatment of cancer.

During this article, we will discuss the biology of PI3K-伪, its role in cancer progression, and its potential as a drug target and biomarker.

Biography of PI3K-伪

PI3K-伪 is a 21-kDa protein that is expressed in various tissues, including neurons, endothelial cells, and immune cells. It is a key component of the PI3K signaling pathway, which is a well-established target for various diseases, including cancer . The PI3K signaling pathway is a complex process that involves the recruitment of various signaling molecules to the PI3K receptor, which is located on the surface of these cells. Once the PI3K receptor is activated, it triggers a series of downstream signaling pathways that regulate cell growth, survival, and angiogenesis.

PI3K-伪 is a key protein that links the PI3K signaling pathway to various cellular processes, including cell adhesion, migration, and the regulation of cell survival. It plays a crucial role in the regulation of angiogenesis, which is the process by which new blood vessels are formed to supply oxygen and nutrients to the growing body. During angiogenesis, PI3K-伪 is involved in the regulation of blood vessel diameter, cell proliferation, and the migration of endothelial cells.

In addition to its role in angiogenesis, PI3K-伪 is also involved in the regulation of cell survival and cell proliferation. It has been shown to play a role in the regulation of cell cycle progression, cell apoptosis, and the regulation of cell survival signaling pathways, including the p53 pathway.

Role in Cancer Progression

The PI3K-伪 signaling pathway has been implicated in the progression of cancer. Several studies have shown that PI3K-伪 is involved in the regulation of various cellular processes that are critical for cancer cell growth and survival, including the regulation of cell cycle progression, cell apoptosis, angiogenesis, and the regulation of signaling pathways that support cancer growth.

One of the key ways in which PI3K-伪 contributes to cancer progression is its role in the regulation of angiogenesis. Angiogenesis is the process by which new blood vessels are formed to supply oxygen and nutrients to the growing body, and it is a critical process for the development and maintenance of cancer tumors. PI3K-伪 has been shown to play a role in the regulation of angiogenesis by regulating the diameter of blood vessels and the migration of endothelial cells.

In addition to its role in angiogenesis, PI3K-伪 has also been shown to contribute to the progression of cancer by regulating cell apoptosis, cell cycle progression, and the regulation of signaling pathways that support cancer growth. For example, PI3K-伪 has been shown to play a role in the regulation of the p53 pathway, which is a critical signaling pathway that regulates apoptosis. The p53 pathway is involved in the regulation of cell cycle progression, apoptosis, and the regulation of DNA damage repair, and it is a key factor in the regulation of cancer cell survival.

Potential as a Drug Target

targeting PI3K-伪 has emerged as a promising strategy for the treatment of cancer due to its involvement in the regulation of various cellular processes that are critical for cancer cell growth and survival. Several studies have shown that targeting PI3K-伪 with small molecules can inhibit its

Protein Name: Phosphoinositide-3-kinase Regulatory Subunit 1

Functions: Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling (PubMed:17626883, PubMed:19805105, PubMed:7518429). Modulates the cellular response to ER stress by promoting nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement (PubMed:20348923)

The "PIK3R1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIK3R1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets